Overview
Turbine, a virtual biology company specializing in AI-powered drug discovery, has raised $25 million in a Series B financing round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors including MSD Global Health Innovation, Accel, and Mercia. The funding will help Turbine expand its platform into immunology, marking a shift beyond oncology.
Products
Loading...
Recent Deals
Investors: Interactive Venture Partners, Beiersdorf AG, MSD Global Health Innovation, Accel, Mercia
Turbine, a virtual biology company specializing in AI-powered drug discovery, has raised $25 million in a Series B financing round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors including MSD Global Health Innovation, Accel, and Mercia. The funding will help Turbine expand its platform into immunology, marking a shift beyond oncology.